Only a small number of U.S. women at high risk of breast cancer have chosen to use the drug tamoxifen to lower that risk, according to a study published Monday.
In 2005, government researchers found, about 51,500 U.S. women were using tamoxifen in order to lower their risk of breast cancer.
For comparison, findings from a 2000 [...]

Researchers with the National Cancer Institute (NCI) have found that the prevalence of tamoxifen use for the prevention of breast cancer among women without a personal history of breast cancer is very low.
Tamoxifen can reduce the risk of developing breast cancer in women who are at increased risk for developing the disease. Details of this [...]

The cancer drug Herceptin combined with chemotherapy works better than chemotherapy alone in patients with a certain type of advanced or inflammatory breast cancer, doctors said on Friday.
They said the drug, a billion-dollar seller for Swiss drugmaker Roche, was particularly effective for many women with advanced or inflammatory breast cancer because many of them have [...]

Case Western Reserve University School of Medicine has been awarded six Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP) grants for innovative medical research. The grants, totaling nearly $2.8 million, will advance research in the field of breast cancer.
Case Western Reserve School of Medicine investigators received three postdoctoral awards and three Idea Awards. [...]